Fecal microbiota transplantation

FMT Basics - The Gut Reset

• Concept: Infusion of a fecal suspension from a healthy donor into the GI tract of a recipient to restore a healthy gut microbiome.
• Primary Goal: Displace pathogenic organisms (like C. difficile) and restore microbial diversity.
• Main Indication: Recurrent Clostridioides difficile infection (rCDI), particularly after ≥2 recurrences unresponsive to standard antibiotics.
• Donor Screening: Crucial step involving rigorous testing of blood and stool for a wide array of bacterial, viral, and parasitic pathogens.

⭐ For recurrent C. difficile, FMT demonstrates superior efficacy, with resolution rates often exceeding 90%, significantly higher than prolonged vancomycin tapers.

Indications & Efficacy - A Gut Feeling

• Primary Indication: Recurrent Clostridioides difficile infection (rCDI).

  • Generally considered after ≥2-3 recurrences despite standard antibiotic therapy (e.g., vancomycin, fidaxomicin).

• Efficacy: High resolution rates for rCDI, often >90%.

  • Mechanism: Restores a healthy, diverse gut microbiome (↑ Firmicutes & Bacteroidetes), which outcompetes C. diff.

• Investigational Uses:
  • Inflammatory Bowel Disease (Ulcerative Colitis > Crohn's Disease).
  • Irritable Bowel Syndrome (IBS).
  • Metabolic syndrome & obesity.
  • Refractory hepatic encephalopathy.

⭐ The strongest evidence for FMT is in treating recurrent C. difficile infection, significantly reducing recurrence rates compared to antibiotics alone.

Procedure & Risks - Guts & Glory

• Screening & Prep: Healthy donor stool is rigorously screened for pathogens, then homogenized, filtered, and prepared for transfer.
• Administration Routes:
  • Lower GI: Colonoscopy (most common), enema.
  • Upper GI: Nasogastric/nasoduodenal tube, or oral encapsulated forms (avoids procedural risks).

• Risks & Complications:
  • Procedure-related: Perforation, bleeding (colonoscopy); aspiration (NG tube).
  • Infectious: Transmission of undetected pathogens (e.g., bacteria, viruses).
  • Common/Mild: Transient fever, bloating, cramping, diarrhea.

⭐ FDA Warning: FMT is regulated as an investigational new drug. There's a risk of transmitting multi-drug resistant organisms; cases of bacteremia and death from drug-resistant E. coli have been reported, mandating enhanced donor screening.

• FMT is the most effective therapy for recurrent C. difficile infection (rCDI), particularly after ≥2 recurrences.
• It works by restoring gut microbial diversity, which suppresses C. diff growth and prevents spore germination.
• Demonstrates superior efficacy over vancomycin or fidaxomicin for preventing subsequent rCDI episodes.
• Involves infusion of stool from a healthy, screened donor, most commonly via colonoscopy.
• Rigorous donor screening is mandatory to prevent transmitting pathogens like HIV, hepatitis, or MDROs.